Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.90B | $1.99B | $2.14B | $2.22B | $2.39B | $3.98B | $5.24B | $3.79B | $2.98B | $2.73B |
| Revenue growth | — | 4.5% | 7.4% | 4.0% | 7.7% | 66.4% | 31.6% | -27.7% | -21.3% | -8.5% |
| Gross profit | $620M | $644M | $696M | $743M | $792M | $1.31B | $1.72B | $1.25B | $919M | $774M |
| Gross margin | 32.6% | 32.4% | 32.6% | 33.5% | 33.1% | 32.9% | 32.7% | 33.0% | 30.8% | 28.3% |
| Operating income | $192M | $212M | $203M | $177M | $149M | $478M | $647M | $338M | -$103M | -$55.5M |
| Operating margin | 10.1% | 10.7% | 9.5% | 8.0% | 6.2% | 12.0% | 12.3% | 8.9% | -3.4% | -2.0% |
| Net income | $106M | $133M | $142M | $114M | $70.7M | $327M | $444M | $211M | -$147M | -$95.7M |
| Net margin | 5.6% | 6.7% | 6.6% | 5.1% | 3.0% | 8.2% | 8.5% | 5.6% | -4.9% | -3.5% |
| EPS (diluted) | $2.15 | $2.68 | $2.91 | $2.40 | $1.48 | $6.81 | $9.90 | $5.36 | -$3.85 | -$2.48 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $134M | $161M | $227M | $225M | $257M | $305M | $654M | $372M | $320M | $269M |
| Capital expenditures | $22.0M | $26.5M | $35.2M | $35.2M | $37.7M | $53.6M | $75.8M | $104M | $80.9M | $35.6M |
| Free cash flow | $112M | $134M | $192M | $190M | $219M | $252M | $578M | $268M | $240M | $234M |
| Share buybacks | $13.3M | $20.2M | $67.0M | $18.7M | $0.00 | $2.69M | $577M | $425M | $0.00 | $0.00 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $10.6M | $15.1M | $13.9M | $83.0M | $29.2M | $181M | $64.5M | $32.9M | $10.6M | $34.0M |
| Total assets | $1.19B | $1.25B | $1.49B | $1.93B | $2.35B | $3.13B | $2.89B | $2.92B | $2.42B | $2.09B |
| Total liabilities | $737M | $691M | $854M | $1.19B | $1.53B | $1.97B | $1.84B | $2.09B | $1.71B | $1.45B |
| Long-term debt | $359M | $320M | $441M | $617M | $858M | $842M | $844M | $1.30B | $1.06B | $767M |
| Shareholders' equity | $449M | $563M | $639M | $737M | $820M | $1.16B | $1.04B | $831M | $707M | $642M |
| Retained earnings | $9.67M | $142M | $286M | $400M | $470M | $797M | $1.24B | $1.45B | $1.30B | $1.21B |
| Shares (wtd avg diluted) | 49.3M | 49.4M | 48.7M | 47.6M | 47.7M | 48.0M | 44.9M | 39.3M | 38.2M | 38.5M |
Every figure is extracted from AMN HEALTHCARE SERVICES INC’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.